Product Information
OMNITROPE 5 MG/1.5 ML CRTG is a brand product labeled by Sandoz Inc., priced at $430.3634 per ML under NDC 00781300107. Its NADAC has been published 111 times since Aug 21, 2024.
Strength
5 mg/1.5mL
Manufacturer
Sandoz Inc.NDC
00781300107
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/1/2026
Active Ingredients
SOMATROPINApproval Type
Biologic (BLA)
FDA Application
BLA021426On Market Since
5/30/2006
Pharmacological Classes
Price Statistics
The NADAC for OMNITROPE 5 MG/1.5 ML CRTG has been published 111 times since Aug 21, 2024, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $430.3634 per ML |
|---|---|
| All-time high | $430.3634 (Sep 30, 2026) |
| All-time low | $405.6667 (Aug 21, 2024) |
| 52-week high | $430.3634 |
| 52-week low | $417.8367 |
| Median price | $417.8367 |
| Average price | $420.0452 |
| Largest weekly change | +3.0% (Jan 8, 2025) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Somatropin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Somatropin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Recombinant Human Growth Hormone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMNITROPE 5 MG/1.5 ML CRTG?
The current National Average Drug Acquisition Cost (NADAC) for OMNITROPE 5 MG/1.5 ML CRTG, manufactured by Sandoz Inc., is $430.3634 per ML (NDC 00781300107), effective Sep 30, 2026.
How has the price of OMNITROPE 5 MG/1.5 ML CRTG changed over time?
Over the history we have for it, the NADAC for OMNITROPE 5 MG/1.5 ML CRTG has risen 6.1%. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for OMNITROPE 5 MG/1.5 ML CRTG?
Since Aug 21, 2024, the NADAC for OMNITROPE 5 MG/1.5 ML CRTG has ranged from a low of $405.6667 (Aug 21, 2024) to a high of $430.3634 (Sep 30, 2026), with a median of $417.8367 per ML.
Are there cheaper alternatives to OMNITROPE 5 MG/1.5 ML CRTG?
No other NADAC-published product currently shares the active ingredient and strength of OMNITROPE 5 MG/1.5 ML CRTG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMNITROPE 5 MG/1.5 ML CRTG?
OMNITROPE 5 MG/1.5 ML CRTG (NDC 00781300107) is labeled by Sandoz Inc., and CMS classifies it as a brand product.